Home » Topics » BioWorld Science

BioWorld Science
RSS

Levemir receives European approval

June 9, 2004

Incara to revise phase I protocol for AEOL-10150

June 9, 2004

Merck KGaA to return Theratope rights to Biomira

June 9, 2004

Istalol NDA for glaucoma approved

June 9, 2004

Alteplase filed for approval in Japan

June 9, 2004

Tosufloxacin tosilate eye drops submitted for Japanese approval

June 9, 2004

European approval for Abilify for schizophrenia

June 9, 2004

Sumitomo licenses licofelone for Japan

June 9, 2004

Selective inhibitor of glycogen synthase kinase-3 stimulates glucose uptake in adipocytes

June 9, 2004

Mechanism of fluid retention by PPAR agonist GI-2570X

June 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...